Log In
Print
BCIQ
Print
Print this Print this
 

MabThera, Rituxan, rituximab (R105, RG105)

Also known as: IDEC-C2B8

  Manage Alerts
Collapse Summary General Information
Company Biogen Idec Inc.
DescriptionChimeric mAb against CD20 antigen
Molecular Target CD20
Mechanism of ActionBinds CD20
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today